Meet Krenare Bruqi, a doctoral student from Kosovo conducting research at the University of Lyon 1. Her focus is on exploring a natural variant of the autophagic receptor NDP52 as a potential target for innovative treatments in Alzheimer's disease. Krenare holds a Master's degree in Biotechnology from the University of Rome Tor Vergata, Italy.
21 авг 2024